Greenstone Announced A Supply Agreement With Roman For Branded Generics Market


Off-invoice discounts available on these generics are propelling the growth of the global branded generics market. For example, in developed countries such as the U.S., the demand for branded generic drugs is expected to be high, owing to higher discounts offered by players. The off-invoice discounts are approximately 30% in the U.S. as compared to 17% in the EU. Factor such as differentiation in color, taste, shape, preservatives, inactive ingredients, and packaging is projected to create high demand for branded generics. Moreover, key players are focussing on improving their share in the market and this will favor the growth of the market in the near future. For example, in January 2020, Endo International plc announced that one of its operating companies, Par Pharmaceutical, has begun shipping an authorized generic version of Allergan's Carafate (sucralfate) oral suspension 1gm/10 mL to the U.S.

The Asia Pacific is expected to dominate the overall market in the near future and this is attributed to the emerging countries in the region. According to the Coherent Market Insights analysis, China, India, and Asia Pacific will lead the global branded generics market through 2029.

  1. In January 2020, Greenstone, a wholly-owned subsidiary of Pfizer Inc., announced a supply agreement with Roman, an innovative digital healthcare clinic, to offer Roman members access to the only FDA-approved authorized generic version of Viagra (sildenafil citrate)

  2. In November 2019, Novo Nordisk has announced its plan to offer an authorized generic or follow-on brand version of insulin aspart and insulin aspart mix at 50% off the current list price for its NovoLog and NovoLog Mix, in January 2020

  3. In January 2020, Greenstone, a wholly-owned subsidiary of Pfizer Inc., announced a supply agreement with Roman, an innovative digital healthcare clinic, to offer Roman members access to the only FDA-approved authorized generic version of Viagra (sildenafil citrate).

  4. In October 2020, Generic Aadhaar announced the launch of generic medicines for thyroid, hypertension, diabetes, antifungal, gastroenterology, lipidemic, and pain management which will be available at a minimum 50 percent price of already existing branded medicines in the market.

Branded Generics, sometimes called Generic Drugs is a boon to those with chronic ailments, such as asthma, who otherwise would not have been able to afford expensive medication. Branded Generics is only part of it, however, as there are many injectable, nasal and over-the-counter drugs as well. Although these products can sometimes be more costly than generic drugs, they can often be bought in bulk and are much cheaper than other health insurance plans. With healthcare costs rising rapidly, generics have become the preferred solution to fill in the gap between demand and supply.

Comments

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027